Gerald J. Goldenberg

2.9k total citations
78 papers, 2.3k citations indexed

About

Gerald J. Goldenberg is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Gerald J. Goldenberg has authored 78 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 17 papers in Oncology and 14 papers in Organic Chemistry. Recurrent topics in Gerald J. Goldenberg's work include Cancer therapeutics and mechanisms (12 papers), Synthesis and Biological Evaluation (12 papers) and Retinoids in leukemia and cellular processes (9 papers). Gerald J. Goldenberg is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), Synthesis and Biological Evaluation (12 papers) and Retinoids in leukemia and cellular processes (9 papers). Gerald J. Goldenberg collaborates with scholars based in Canada, United States and Israel. Gerald J. Goldenberg's co-authors include Asher Begleiter, Abdul M. Deffie, Janendra K. Batra, K. Henry, D. A. G. Galton, J M Goldman, E. Wiltshaw, Daniel Catovsky, Hing-Yat Peter Lam and I. Bihler and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Gerald J. Goldenberg

78 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald J. Goldenberg Canada 27 1.3k 870 334 311 294 78 2.3k
M Potmĕsil United States 23 2.4k 1.9× 1.6k 1.8× 461 1.4× 230 0.7× 267 0.9× 60 3.3k
Donna Headlee United States 24 1.5k 1.1× 1.1k 1.2× 236 0.7× 330 1.1× 210 0.7× 34 2.7k
D B Wasson United States 22 1.2k 0.9× 576 0.7× 554 1.7× 326 1.0× 223 0.8× 39 2.2k
Eric Scholar United States 18 893 0.7× 581 0.7× 102 0.3× 279 0.9× 131 0.4× 27 1.8k
Carlos J. Carrera United States 22 1.0k 0.8× 621 0.7× 866 2.6× 336 1.1× 404 1.4× 35 2.2k
Carlo M. Croce United States 22 2.4k 1.8× 607 0.7× 495 1.5× 604 1.9× 317 1.1× 31 3.6k
Takashi Kasukabe Japan 28 1.8k 1.4× 418 0.5× 113 0.3× 285 0.9× 315 1.1× 101 2.5k
Lou A. Smets Netherlands 32 1.7k 1.3× 566 0.7× 148 0.4× 353 1.1× 103 0.4× 97 2.9k
Erin R. Gardner United States 25 1.5k 1.2× 1.1k 1.2× 201 0.6× 226 0.7× 281 1.0× 49 2.9k
Juhani Vilpo Finland 25 1.4k 1.1× 462 0.5× 872 2.6× 653 2.1× 677 2.3× 115 2.8k

Countries citing papers authored by Gerald J. Goldenberg

Since Specialization
Citations

This map shows the geographic impact of Gerald J. Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald J. Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald J. Goldenberg more than expected).

Fields of papers citing papers by Gerald J. Goldenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald J. Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald J. Goldenberg. The network helps show where Gerald J. Goldenberg may publish in the future.

Co-authorship network of co-authors of Gerald J. Goldenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald J. Goldenberg. A scholar is included among the top collaborators of Gerald J. Goldenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald J. Goldenberg. Gerald J. Goldenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Findley, Harry W., et al.. (2002). Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines. Leukemia Research. 26(5). 503–513. 8 indexed citations
2.
Salmena, Leonardo, et al.. (2001). Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIα expression☆. Biochemical Pharmacology. 61(7). 795–802. 29 indexed citations
3.
Salmena, Leonardo, Jodi Lees, William Chu, et al.. (1999). p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin. Leukemia Research. 23(10). 871–880. 27 indexed citations
4.
Squire, Jeremy A., J. Peter McPherson, Barbara Beatty, & Gerald J. Goldenberg. (1996). Allelic fusion of DNA topoisomerase IIα and retinoic acid receptor α genes in Adriamycin-resistant p388 murine leukemia revealed by fluorescence in situ hybridization. Cytogenetic and Genome Research. 75(2-3). 164–166. 1 indexed citations
5.
Miller, Lorraine K., Abdul M. Deffie, Ratna Bose, & Gerald J. Goldenberg. (1992). Modulation of melphalan uptake in murine L5178Y lymphoblasts in vitro by changes in ionic environment. Biochemical Pharmacology. 43(5). 1154–1158. 7 indexed citations
6.
7.
Begleiter, Asher, et al.. (1991). Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia. Leukemia Research. 15(11). 1019–1027. 13 indexed citations
8.
Johnston, James B., et al.. (1990). Glutathione S-Transferase Activity, Sulfhydryl Group and Glutathione Levels, and DNA Cross-Linking Activity With Chlorambucil in Chronic Lymphocytic Leukemia. JNCI Journal of the National Cancer Institute. 82(9). 776–779. 34 indexed citations
9.
10.
Patarca, Roberto, Catherine V. Heath, Gerald J. Goldenberg, et al.. (1987). Transcription Directed by the HIV Long Terminal Repeat In Vitro. AIDS Research and Human Retroviruses. 3(1). 41–55. 21 indexed citations
11.
Cheang, Mary, et al.. (1986). Comparison of adriamycin uptake in chick embryo heart and liver cells an murine L5178Y lymphoblasts in vitro: role of drug uptake in cardiotoxicity.. PubMed. 46(1). 218–23. 33 indexed citations
12.
Goldenberg, Gerald J., et al.. (1985). Anatagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro. Biochemical Pharmacology. 34(6). 763–770. 48 indexed citations
13.
Goldenberg, Gerald J. & Asher Begleiter. (1980). Membrane transport of alkylating agents. Pharmacology & Therapeutics. 8(2). 237–274. 42 indexed citations
14.
Goldenberg, Gerald J. & Wilfred D. Stein. (1978). Increase in the affinity of the uridine phosphorylation system for ATP after serum or insulin activation of 3T3 fibroblasts. Journal of Supramolecular Structure. 9(4). 489–496. 2 indexed citations
15.
Goldenberg, Gerald J.. (1974). Drug-induced stimulation of nitrogen mustard and choline transport and other systems in L5178Y lymphoblasts in vitro.. The Mouseion at the JAXlibrary (Jackson Laboratory). 34(10). 2511–6. 13 indexed citations
16.
Israels, L. G., et al.. (1974). δ-aminolevulinic acid transport and synthesis, porphyrin synthesis and heme catabolism in chick embryo liver and heart cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 372(1). 32–38. 7 indexed citations
17.
Lyons, Roger M. & Gerald J. Goldenberg. (1972). Active transport of nitrogen mustard and choline by normal and leukemic human lymphoid cells.. PubMed. 32(8). 1679–85. 21 indexed citations
18.
Goldenberg, Gerald J., F. Paraskevas, & Lyonel G. Israels. (1971). Lymphocyte and plasma cell neoplasms associated with autoimmune diseases. Seminars in Arthritis and Rheumatism. 1(2). 174–193. 20 indexed citations
19.
Goldenberg, Gerald J.. (1969). PROPERTIES OF L5178Y LYMPHOBLASTS HIGHLY RESISTANT TO NITROGEN MUSTARD*. Annals of the New York Academy of Sciences. 163(2). 936–953. 25 indexed citations
20.
Goldenberg, Gerald J., et al.. (1967). Virus-like Particles in Murine Leukaemia L5178Y. Nature. 214(5095). 1339–1341. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Potmĕsil Breakdown of academic impact, for papers by Donna Headlee Breakdown of academic impact, for papers by D B Wasson Breakdown of academic impact, for papers by Eric Scholar Breakdown of academic impact, for papers by Carlos J. Carrera Breakdown of academic impact, for papers by Carlo M. Croce Breakdown of academic impact, for papers by Takashi Kasukabe Breakdown of academic impact, for papers by Lou A. Smets Breakdown of academic impact, for papers by Erin R. Gardner Breakdown of academic impact, for papers by Juhani Vilpo
Rankless by CCL
2026